Background {#Sec1}
==========

Cardiac magnetic resonance imaging (CMR) can accurately delineate myocardial scar for substrate guided ventricular tachycardia (VT) ablation. Susceptibility artifact from cardiac rhythm management device (CRMD) generator and leads can significantly affect image quality limiting the evaluation of myocardial scar and foci of VT. We conducted a retrospective study to correlate scars from CMR to the voltage mapping obtained at electrophysiology study (EPS).

Methods {#Sec2}
=======

We studied 27 patients with CRMD who underwent CMR and EPS at Loyola University Medical Center between 11/2012 to 9/2014. Baseline demographics and clinical parameters are outlined (Table [1](#Tab1){ref-type="table"}). A total of 432 left ventricular (LV) segments were analyzed for wall motion and late gadolinium enhancement using the AHA 17 segment model excluding the apical cap. The presence of right ventricular (RV) scar and wall motion abnormalities was also recorded. Data from the EPS included the type of access (endocardial and/or epicardial), the presence and location of scar, and the VT foci.Table 1Baseline clinical parametersAge (years)58.52 +/- 14.82Male/Female(25/2)Ischemic cardiomyopathy16(59%)Non-ischemic cardiomyopathy11 (41%)Diabetes mellitus4(15%)Hypertension14(52%)Hyperlipidemia14(52%)Smoking10(37%)Body mass index (kg/m2)26.5+/- 6.3Body surface area (m2)2 +/-0.14Left Ventricular Ejection Fraction (% +/- standard deviation)41.23+/-16.73Left ventricular end-diastolic volume index (% +/- standard deviation)133.45 +/-14.2Right Ventricular Ejection Fraction (% +/- standard deviation)44.31 +/- 12.06Right ventricular end-diastolic volume index (% +/- standard deviation)96.84 +/- 35.89Pacemaker/ICD2/25

Results {#Sec3}
=======

Of the 432 LV segments, 127 (29.3%) were affected by artifact precluding assessment for myocardial scar. The mid anterior (81.4%) and basal inferior (3.7%) segments were the most and least affected by artifact respectively. CMR scar parameters were compared with EPS scar mapping (Table [2](#Tab2){ref-type="table"}). CMR was able to identify LV scar, particularly endocardial scar, in most cases despite the presence of device-related artifact. In 17/22 patients (77.3%) with CMR identified LV scar, the LV endocardial scar location on CMR was comparable to the voltage map at EPS. In only one patient was LV endocardial scar missed on CMR in a non-evaluable segment due to artifact, although that segment did have a wall motion abnormality. Exclusion of LV endocardial scar by CMR is associated with a low diagnostic yield of endocardial mapping at EPS. In 18/22 (81.8%) patients with inducible VT, the focus of VT arose from an area delineated as scar on CMR. In the remaining 4 patients, only one patient had inducible VT unrelated to MRI scar. Of the ten RV scars identified at EPS, only 4 were detected by DE-MRI.Table 2Comparison of MRI and EPS parametersCMR parameterEPS parameterCo-efficient of correlationP-value95% confidence interval for rSample sizeCMR-All LV scarEPS-All LV scar0.59p\<0.00250.24-0.824CMR-LV endocardial scarEPS-LV endocardial scar0.83p\<0.00010.64-0.9224CMR-LV epicardial scarEPS-LV epicardial scar0.65p=0.078-0.09-0.938CMR-LV wall motion abnormalityEPS-LV endocardial scar0.49p=0.00920.14-0.7327CMR-RV scarEPS-RV scar0.57p=0.00310.22-0.7924CMR-RV wall motion abnormalityEPS-RV scar0.42p=0.0280.05-0.6927

Conclusions {#Sec4}
===========

CMR can be a valuable tool in localizing LV scar prior to EPS for ablation of VT. However, 29.3% of LV segments are not evaluable due to artifact from device generator (anterior wall in 65.4%). Regional wall motion abnormalities in non-evaluable left and right ventricular segments can guide identification of scar at EPS.
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